Sultana S Banu1, Wieland Meyer2, Be-Nazir Ahmed3, Rady Kim4, Rogan Lee5. 1. Parasitology Department, Centre for Infectious Diseases and Microbiology Laboratory Services (CIDMLS), ICPMR, Westmead Hospital, NSW, Australia Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Marie Bashir Institute, Westmead Institute for Medical Research, NSW, Australia Discipline of Medicine, Sydney Medical School, University of Sydney, NSW, Australia Communicable Disease Control Unit, Directorate General of Health Services, Mohakhali, Dhaka, Bangladesh. sban7118@uni.sydney.edu.au. 2. Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Marie Bashir Institute, Westmead Institute for Medical Research, NSW, Australia Discipline of Medicine, Sydney Medical School, University of Sydney, NSW, Australia. 3. Communicable Disease Control Unit, Directorate General of Health Services, Mohakhali, Dhaka, Bangladesh. 4. Parasitology Department, Centre for Infectious Diseases and Microbiology Laboratory Services (CIDMLS), ICPMR, Westmead Hospital, NSW, Australia. 5. Parasitology Department, Centre for Infectious Diseases and Microbiology Laboratory Services (CIDMLS), ICPMR, Westmead Hospital, NSW, Australia Discipline of Medicine, Sydney Medical School, University of Sydney, NSW, Australia.
Abstract
BACKGROUND: The majority of individuals infected with Leishmania donovani complex remain asymptomatic. They may act as transmission reservoirs for visceral leishmaniasis (VL). We investigated sero-prevalence of L. donovani complex amongst those closely associated with patients with VL and whether these sero-reactive individuals had Leishmania parasites in their peripheral blood. Other risk factors were also investigated. METHODS: A total of 257 individuals in contact with patients with VL were tested for anti-Leishmania antibodies by rK39 immunochromatographic test (rK39 ICT), ELISA using promastigote antigen (p-ELISA) and indirect fluorescent antibody test (IFAT). Buffy coats of rK39 ICT positive individuals were cultured; sero-reactive buffy coats were tested for Leishmania DNA by ITS1 PCR. DNA obtained from culture was sequenced to confirm Leishmania species. Risk factors were evaluated for each sero-positive sample. RESULTS: The results showed 29.2% (75/257) prevalence by serological tests: 14.4% (37/257) were positive by rK39 ICT, 25.3% (65/257) by p-ELISA, 18.3% (47/257) by IFAT and 10.9% (28/257) by all three serological methods. Ten percent (3/30) of cultures were positive for Leishmania promastigotes. Only 3% (2/74) sero-reactive buffy coats were positive for DNA; sequence analysis revealed L. donovani species. Significant risk factors were age, working as farmers, domestic animals in household and proximity to animal shelters. CONCLUSIONS: Asymptomatic family members of patients with VL can carry live L. donovani in peripheral blood and may act as potential reservoirs. GENBANK ACCESSION NUMBER: BankIt1863680 Leishmania KT921417 (DNA sequences of the ribosomal ITS1 region of L. donovani).
BACKGROUND: The majority of individuals infected with Leishmania donovani complex remain asymptomatic. They may act as transmission reservoirs for visceral leishmaniasis (VL). We investigated sero-prevalence of L. donovani complex amongst those closely associated with patients with VL and whether these sero-reactive individuals had Leishmania parasites in their peripheral blood. Other risk factors were also investigated. METHODS: A total of 257 individuals in contact with patients with VL were tested for anti-Leishmania antibodies by rK39 immunochromatographic test (rK39 ICT), ELISA using promastigote antigen (p-ELISA) and indirect fluorescent antibody test (IFAT). Buffy coats of rK39 ICT positive individuals were cultured; sero-reactive buffy coats were tested for Leishmania DNA by ITS1 PCR. DNA obtained from culture was sequenced to confirm Leishmania species. Risk factors were evaluated for each sero-positive sample. RESULTS: The results showed 29.2% (75/257) prevalence by serological tests: 14.4% (37/257) were positive by rK39 ICT, 25.3% (65/257) by p-ELISA, 18.3% (47/257) by IFAT and 10.9% (28/257) by all three serological methods. Ten percent (3/30) of cultures were positive for Leishmania promastigotes. Only 3% (2/74) sero-reactive buffy coats were positive for DNA; sequence analysis revealed L. donovani species. Significant risk factors were age, working as farmers, domestic animals in household and proximity to animal shelters. CONCLUSIONS: Asymptomatic family members of patients with VL can carry live L. donovani in peripheral blood and may act as potential reservoirs. GENBANK ACCESSION NUMBER: BankIt1863680 Leishmania KT921417 (DNA sequences of the ribosomal ITS1 region of L. donovani).
Authors: Karl Schenkel; Suman Rijal; Siddhartha Koirala; Shekhar Koirala; Veerle Vanlerberghe; Patrick Van der Stuyft; Marina Gramiccia; Marleen Boelaert Journal: Trop Med Int Health Date: 2006-12 Impact factor: 2.622
Authors: T G Evans; M J Teixeira; I T McAuliffe; I Vasconcelos; A W Vasconcelos; A de A Sousa; J W Lima; R D Pearson Journal: J Infect Dis Date: 1992-11 Impact factor: 5.226
Authors: Caryn Bern; Allen W Hightower; Rajib Chowdhury; Mustakim Ali; Josef Amann; Yukiko Wagatsuma; Rashidul Haque; Katie Kurkjian; Louise E Vaz; Moarrita Begum; Tangin Akter; Catherine B Cetre-Sossah; Indu B Ahluwalia; Ellen Dotson; W Evan Secor; Robert F Breiman; James H Maguire Journal: Emerg Infect Dis Date: 2005-05 Impact factor: 6.883
Authors: Gabriel Reis Ferreira; José Carlos Castelo Branco Ribeiro; Antônio Meneses Filho; Teresinha de Jesus Cardoso Farias Pereira; Daniela Moura Parente; Humberto Feitosa Pereira; Jailthon Carlos da Silva; Danielle Alves Zacarias; Letiano Vieira da Silva; Symonara Karina Medeiros Faustino; Walfrido Salmito Almeida Neto; Dorcas Lamounier Costa; Ivete Lopes de Mendonça; Carlos Henrique Nery Costa Journal: Am J Trop Med Hyg Date: 2018-01 Impact factor: 2.345
Authors: Ana Victoria Ibarra-Meneses; Audrey Corbeil; Victoria Wagner; Chukwuemeka Onwuchekwa; Christopher Fernandez-Prada Journal: Parasit Vectors Date: 2022-01-05 Impact factor: 3.876